The pharmaceutical supply chain in Iraq is governed by a structured licensing regime designed to ensure that medicines move from manufacturer to patient through accountable, qualified, and inspectable channels. Wholesalers, traditionally known as drugstores (مخازن أدوية) — occupy a central position in this chain. They are the intermediary that connects manufacturers and importers to the pharmacies and hospitals that ultimately dispense to patients. The legal and practical importance of the wholesaler tier is often underestimated, but failures at this level, temperature excursions, traceability gaps, diversion, have direct consequences for patient safety and for the regulatory standing of every other participant in the chain.
A drugstore in Iraq is a legally defined pharmaceutical wholesale establishment, distinct from a retail pharmacy and from a scientific office. It is authorized to purchase, store, and distribute medicines to licensed entities such as pharmacies, hospitals, and other licensed institutions, but it cannot sell directly to the public. Drugstore licensing is administered by the Ministry of Health and addresses premises, personnel, financial guarantees, and operational compliance.
Licensing Requirements
The premises must be suitable for the storage of pharmaceuticals, with controlled temperature, humidity, and security. Cold storage facilities are required for refrigerated products, and the layout must permit segregation of receiving, quarantine, approved stock, returns, recalls, and dispatch areas. Municipal and zoning compliance, civil defense, and fire safety requirements are part of the licensing package, and the technical director, a qualified Iraqi pharmacist, must be present during operating hours. Financial guarantees, the amount and form of which are set by the Ministry, are typically required as a condition of licensing; they serve both to demonstrate operational capacity and to provide a fund for potential regulatory enforcement.
Good Distribution Practice
Once licensed, the drugstore must operate in accordance with Good Distribution Practice principles adopted by the Ministry of Health. The practical core of GDP is the principle that the wholesaler must purchase medicines only from authorized sources, licensed manufacturers, licensed importers, or other licensed wholesalers, and must sell only to authorized recipients. Sales to unauthorized parties expose the wholesaler to significant regulatory and criminal liability, and this is one of the areas where regulators are most vigilant.
Every transaction must be documented with sufficient detail to permit traceability of each batch from receipt to onward sale. Records must be maintained for at least five years and must be available for inspection at any time. Storage conditions must be maintained continuously, with temperature monitoring and documentation of any excursions. Cold chain products must be transported in qualified containers with continuous temperature monitoring, and any quality-affecting deviations must be documented, investigated, and reported. Expired or recalled stock must be quarantined and disposed of through authorized channels, and the wholesaler must be able to identify and segregate affected products quickly when a recall is initiated.
Inspections and Common Findings
Inspections by the Ministry of Health are a routine part of operations. Inspectors review premises, records, personnel qualifications, storage conditions, and compliance with operational procedures. Findings can range from administrative warnings to fines, suspension or revocation of the license, and criminal referral in serious cases. The findings we see most often involve handling of unregistered products, smuggling or diversion, falsified records, and breaches of cold chain or storage requirements. Each of these is treated seriously by the regulator and can result in immediate suspension of operations.
Commercial Arrangements and Regulated Margins
The wholesaler’s margin is set by the Ministry, and deviation from approved margins exposes both the wholesaler and its counterparty to regulatory action. Long-term distribution agreements need to be reviewed periodically to ensure that they remain consistent with regulated margins and with broader contractual provisions on exclusivity, territory, and termination. Distribution arrangements that worked five years ago may no longer fit the current pricing landscape, and a periodic legal review of distribution arrangements is good practice for any wholesaler operating at scale.
Liability Along the Chain
Liability along the supply chain is shared. The manufacturer typically bears primary product liability, but a wholesaler that fails in its storage, distribution, or record-keeping responsibilities can be liable for losses attributable to those failures. Insurance, indemnification, and risk allocation in supply contracts should be structured to reflect the realistic distribution of risk between the parties, and these provisions deserve more attention than they typically receive in standard distribution agreements.
Operational Reality
Operating a compliant drugstore in Iraq is not just a matter of meeting initial licensing requirements; it requires daily attention to receiving processes, temperature monitoring, document control, personnel training, and customer due diligence. Wholesalers that treat compliance as a continuous operational discipline tend to encounter few problems with regulators; those that treat it as a periodic exercise typically discover problems only when an inspection or an incident exposes them. For wholesalers operating across multiple sites or expanding into new product categories such as biologics or controlled substances, the compliance burden grows materially, and the systems and personnel need to scale with it.
How We Can Help
Etihad Law Firm advises pharmaceutical wholesalers, manufacturers, and importers on the licensing, operational compliance, and contractual structuring of pharmaceutical distribution in Iraq. We assist with initial drugstore licensing, supply chain audits, contract negotiation, regulatory disputes, and crisis management in the event of recalls or enforcement actions.